Aclaris Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $197.4M
Liabilities Breakdown FY2023
Total Liabilities: $40.2M
Asset Breakdown
Total Assets: $197.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $39.9M | 20.2% |
| Accounts Receivable | $298.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.6M | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $269.0K | 0.1% |
| Other Assets | $155.3M | 78.7% |
Liabilities Breakdown
Total Liabilities: $40.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.9M | 22.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $31.3M | 77.9% |